Market Place
Sourcing Support
First Children Vaccinated in Study for Nordic’s Mpox Vaccine
29 Oct 2024 //
GLOBENEWSWIRE
NIH study shows mpox shot elicits immune response in teens
17 Oct 2024 //
FIERCE PHARMA
WHO approves Bavarian Nordic`s mpox vaccine for adolescents
11 Oct 2024 //
REUTERS
UNICEF taps Bavarian Nordic for 1M mpox vaccines
27 Sep 2024 //
FIERCE PHARMA
Bavarian Nordic Signs Agreement With UNICEF For Mpox Vaccines
26 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Upgrades its Financial Guidance for 2024
26 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Gets USD 63M for Smallpox/Mpox Vaccine
24 Sep 2024 //
GLOBENEWSWIRE
Bavarian says mpox vaccine approved by EU regulator for adolescents
20 Sep 2024 //
REUTERS
Bavarian Nordic Receives EMA Approval Of Mpox Vaccine
19 Sep 2024 //
GLOBENEWSWIRE
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
18 Sep 2024 //
REUTERS
UK government buys over 150,000 doses of Bavarian Nordic`s mpox vaccine
17 Sep 2024 //
REUTERS
Canada`s Only Single-Dose Cholera Vaccine Available Nationwide
16 Sep 2024 //
GLOBENEWSWIRE
WHO clears Bavarian Nordic`s vaccine for mpox, sets up access scheme
14 Sep 2024 //
REUTERS
Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine
13 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Seeks Partnerships To Boost Mpox Vaccine Production
13 Sep 2024 //
FIERCE PHARMA
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation
12 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Reports Transactions Of Shares By Managerial Staff
06 Sep 2024 //
GLOBENEWSWIRE
Capital Increase In Bavarian Nordic From Warrant Exercise
05 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic`s Mpox Vaccine Arriving In Congo
05 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Reports Transactions Of Shares By Insiders
05 Sep 2024 //
GLOBENEWSWIRE
Moderna`s Mpox Vaccine Shows Better Outcomes in Monkeys Than Bavarian Nordic
05 Sep 2024 //
FIERCE BIOTECH
US FDA approves Emergent`s smallpox vaccine for people at high risk of mpox
30 Aug 2024 //
REUTERS
Singapore approves Bavarian`s mpox vaccine Jynneos
26 Aug 2024 //
REUTERS
DR Congo no longer expects to receive mpox vaccines this week
26 Aug 2024 //
REUTERS
Bavarian Nordic Reports Transactions Of Shares By Managerial Persons
23 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic Announces First Half 2024 Results
22 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic Gets 440,000 Dose Vaccine Contract From European Country
21 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic To Provide 10M Jynneos Doses To Africa Amid Mpox Outbreak
19 Aug 2024 //
FIERCE PHARMA
Bavarian Nordic Addresses Mpox Vaccine Supply And Global Collaboration
17 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic Submits Data To EMA To Extend Mpox/Smallpox Vaccine Approval
16 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic`s Chikungunya Vaccine BLA Gets FDA Priority Review
13 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic Receives HERA Order And Donates Mpox Vaccines To Africa
13 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic To Donate Mpox Vaccine After African Emergency Declaration
13 Aug 2024 //
REUTERS
Bavarian Nordic Receives $156.8M For Vaccine Production From U.S. Gov
08 Aug 2024 //
GLOBENEWSWIRE
Bavarian Nordic Gets $157M Contract For US Smallpox/Mpox Vaccine Supply
08 Aug 2024 //
FIERCE PHARMA
CHMP Backs Bavarian Nordic`s Mpox Vaccine Real-World Data Inclusion
26 Jul 2024 //
GLOBENEWSWIRE
CHMP Backs Mpox Real-World Data For Bavarian Nordic Vaccine In EU
26 Jul 2024 //
GLOBENEWSWIRE
EMA Accepts Bavarian Nordic`s Chikungunya Vaccine MAA Filing
18 Jul 2024 //
GLOBENEWSWIRE
Bavarian Nordic Converts Existing Credit Facility into Sustainability Loan
01 Jul 2024 //
GLOBENEWSWIRE
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
28 Jun 2024 //
GLOBENEWSWIRE
Bavarian Nordic Submits Application For Chikungunya Vaccine
26 Jun 2024 //
GLOBENEWSWIRE
Bavarian Nordic completes BLA submission to U.S. FDA for Chikungunya vaccine
17 Jun 2024 //
GLOBENEWSWIRE
Bavarian Nordic Submits BLA For Freeze-Dried Pox Vaccine In US
31 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa
30 May 2024 //
GLOBENEWSWIRE
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
22 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic CMO de Moerlooze Leaving
21 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic Updates On Share Buyback, Terminates Program
21 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
08 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic Share Buyback For Incentives
08 May 2024 //
GLOBENEWSWIRE
Bavarian Nordic Insider Transactions Report
06 May 2024 //
GLOBENEWSWIRE
Bavarian Rolling BLA with FDA for Chikungunya Vaccine
29 Apr 2024 //
GLOBENEWSWIRE
Bavarian Gets €65M EU Contract for Smallpox Vaccine Reserve
29 Apr 2024 //
GLOBENEWSWIRE
Bavarian Nordic Director/Associate Share Transactions
22 Apr 2024 //
GLOBENEWSWIRE
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
16 Apr 2024 //
GLOBENEWSWIRE
M&D is the First U.S. Distributor for JYNNEOS®, the FDA-approved Mpox Vaccine
03 Apr 2024 //
BUSINESSWIRE
Bavarian Nordic begins commercial launch of mpox vaccine in US
02 Apr 2024 //
FIERCE PHARMA
Bavarian Nordic Notice Convening Annual General Meeting
21 Mar 2024 //
GLOBENEWSWIRE
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland
13 Mar 2024 //
GLOBENEWSWIRE
Report of transactions of shares and related securities of Bavarian Nordic
12 Mar 2024 //
GLOBENEWSWIRE
Bavarian Nordic Publishes Annual Report 2023
06 Mar 2024 //
GLOBENEWSWIRE
